Appellate Tribunal rules in favor of pharmaceutical manufacturer on credit denial for testing services The Appellate Tribunal CESTAT MUMBAI ruled in favor of the appellant, M/s. Wockhardt Ltd., a pharmaceutical manufacturer, in an appeal against the denial ...
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Appellate Tribunal rules in favor of pharmaceutical manufacturer on credit denial for testing services
The Appellate Tribunal CESTAT MUMBAI ruled in favor of the appellant, M/s. Wockhardt Ltd., a pharmaceutical manufacturer, in an appeal against the denial of credit for testing and analyzing services for a product yet to be manufactured. The Tribunal held that such services qualify as eligible input services under Rule 2(l) of the Cenvat Credit Rules, 2004, citing legal precedents. It was determined that the distribution of credit from the head office to a different unit was permissible under Rule 7 of the Rules. Consequently, the Tribunal granted a stay, waiving the pre-deposit of dues and staying the recovery during the appeal's pendency.
Issues: Appeal against order-in-appeal denying credit for testing and analyzing services availed for a product yet to be manufactured. Interpretation of Rule 2(l) of Cenvat Credit Rules, 2004. Distribution of credit by head office to unit at a different location. Prima facie case for grant of stay.
Analysis: The appeal before the Appellate Tribunal CESTAT MUMBAI concerned the denial of credit by the Commissioner of Customs & Central Excise (Appeals) to M/s. Wockhardt Ltd., a pharmaceutical manufacturer, for testing and analyzing services undertaken abroad for a product yet to be manufactured. The appellant contended that such services are part of their manufacturing activity and qualify as eligible input services under Rule 2(l) of the Cenvat Credit Rules, 2004. Reference was made to the Cadila Healthcare Ltd. case, where it was held that services procured for future goods, even if not ultimately manufactured, are eligible for credit. The appellant also argued that the distribution of credit from the head office to the Daman unit was permissible under Rule 7 of the Cenvat Credit Rules, 2004, citing the decision in the CCE, Bangalore Vs. ECOF Industries Pvt. Ltd. case.
The Revenue, represented by the Ld. Additional Commissioner, reiterated the findings of the lower appellate authority, which had rejected the appellant's appeal. However, upon careful consideration of the submissions from both sides, the Tribunal referred to the legal precedents set in the Cadila Healthcare Ltd. case and the ECOF Industries Pvt. Ltd. case. It was noted that the services availed by the appellant qualified as input services, even if the final product was not manufactured, and that the distribution of credit was permissible as long as certain conditions were met, none of which were found to be violated by the appellant.
Consequently, the Tribunal found that the appellant had established a prima facie case in their favor for the grant of a stay. As a result, the Tribunal granted an unconditional waiver from the pre-deposit of dues adjudged against the appellant and stayed the recovery of the same during the pendency of the appeal. The judgment highlighted the importance of interpreting the Cenvat Credit Rules in a manner that allows for the legitimate availment of credit for input services related to manufacturing activities, even if the final product is not realized.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
of 
TaxTMI 
